Edition:
United States

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

78.49USD
24 Mar 2017
Change (% chg)

$0.19 (+0.24%)
Prev Close
$78.30
Open
$78.25
Day's High
$78.66
Day's Low
$78.01
Volume
1,296,365
Avg. Vol
1,877,232
52-wk High
$106.67
52-wk Low
$69.30

Latest Key Developments (Source: Significant Developments)

CVS Health sets quarterly dividend of $0.425 per share
Wednesday, 6 Jul 2016 01:05pm EDT 

CVS Health Corp :Sets quarterly dividend of $0.425 per share.  Full Article

CVS Health announces cash tender offers for certain outstanding notes
Monday, 16 May 2016 10:04am EDT 

Cvs Health Corp : Has commenced cash tender offers for any and all of its 5.75% senior notes due 2017, its 6.60% senior notes due 2019 . Offers for up to $1.5 billion of 6.25% senior notes due 2027,6.125% senior notes due 2039,5.750% senior notes due 2041,5.00% senior notes due 2024 . Purpose of tender offers is to refinance a portion of cvs health's outstanding indebtedness .Cvs health corporation announces cash tender offers for certain outstanding notes.  Full Article

CVS Health Corp Recalls Gold Emblem Abound Organic Spiced Herbal Tea Due to Possible Salmonella - MT Newswires
Monday, 25 Apr 2016 06:34pm EDT 

CVS Health Corp:CVS Health (CVS) said it has recalled select cases of Gold Emblem Abound Organic Spiced Herbal Tea after the maker of the product notified it that it might be contaminated with Salmonella.It said that approximately 200 units of the recalled product were sold prior to the recall. The company noted it is not aware of any reported cases of illness to date.CVS said that an ingredient made by the manufacturer's raw material supplier tested positive for Salmonella in another company's product and noted that the Gold Emblem product also contains this ingredient.The product is labeled "Gold Emblem Abound Organic Spiced Herbal Tea 1.41 oz" and was packed in 1.4 oz cartons.The recalled product has a best by date of 18 Mar 2018 with a UPC code 0 50428 541043. CVS said that no other best by dates are affected. The product was available at CVS Pharmacy stores nationwide.  Full Article

CVS Health Corp announces quarterly dividend
Wednesday, 2 Mar 2016 11:32am EST 

CVS Health Corp:Board of directors has approved a quarterly dividend of $0.425 (42.5 cents) per share on the corporation's common stock.Dividend is payable on May 2 to holders of record date as on April 22.  Full Article

CVS Health Corp confirms FY, Q1 2016 EPS guidance
Tuesday, 9 Feb 2016 06:51am EST 

CVS Health Corp:Confirmed its previous guidance for FY 2016 and Q1 2016.Expects to deliver adjusted EPS of $5.73 to $5.88 and GAAP diluted earnings per share from continuing operations of $5.28 to $5.43 in FY 2016.Confirmed its Q1 2016 adjusted EPS guidance of $1.14 to $1.17 and GAAP diluted earnings per share from continuing operations of $1.03 to $1.06.Adjusted EPS excludes intangible asset amortization and guidance also excludes the affect of acquisition-related integration costs that are expected to occur during 2016.  Full Article

CVS Health and Target announce completed acquisition of Target's Pharmacy and Clinic Businesses
Wednesday, 16 Dec 2015 07:55am EST 

CVS Health Corp and Target Corp:Announce completed acquisition of target's pharmacy and clinic businesses.Closing of transaction is expected to have impact on target's fourth quarter 2015 financial results.Target will recognize a pre-tax gain of $575 million to $775 million following closing of deal.Reduction of expected Q4 sales of approximately $500 million is expected to impact Target, following deal closing.Closing of transaction does not change target's expected fourth quarter comparable sales.Target's after-tax net proceeds from the transaction are expected to be approximately $1.2 billion.  Full Article

CVS Health Corp raises low end of prior FY 2016 EPS guidance
Wednesday, 16 Dec 2015 07:30am EST 

CVS Health Corp:Provides FY 2016 guidance, raising low end of preliminary range by $0.05 per share.Expects FY 2016 adjusted EPS to be in the range of $5.73 to $5.88, up 11.25% to 14.25%.Expects FY 2016 GAAP diluted EPS from continuing operations to be in the range of $5.28 to $5.43.  Full Article

CVS Health Corp announces 21% dividend increase for 2016
Wednesday, 16 Dec 2015 07:30am EST 

CVS Health Corp:Board approved a 21% increase in its quarterly cash dividend, to $0.425 per share on the common stock of the Company.Increase translates to $1.70 per share annually, up $0.30 per share.Increased quarterly dividend will be payable on Feb. 2, 2016, to shareholders of record on Jan. 22, 2016.  Full Article

CVS Health Corp gives Q4 2015 EPS guidance above estimates; raises low end of prior FY 2015 EPS guidance; gives FY 2016 EPS guidance below estimates
Friday, 30 Oct 2015 06:40am EDT 

CVS Health Corp:Expects Q4 2015 adjusted EPS in the range of $1.51-$1.55.Expects FY 2015 adjusted EPS in the range of $5.14-$5.18, up from $5.11-$5.18.Expects FY 2016 EPS in the range of $5.68-$5.88.Q4 2015 EPS of $1.50 - Thomson Reuters I/B/E/S.FY 2015 EPS of $5.16 - Thomson Reuters I/B/E/S.FY 2016 EPS of $6.02 - Thomson Reuters I/B/E/S.  Full Article

CVS Health Corporation Announces Quarterly Dividend
Thursday, 1 Oct 2015 07:54am EDT 

CVS Health Corporation:Approved a quarterly dividend of $0.35 per share on the corporation's common stock.dividend is payable on November 2, 2015, to holders of record on October 22, 2015.  Full Article

More From Around the Web

CVS beats class certification bid in generic drug overcharging case

A federal judge has denied a bid by CVS Health Corp customers for class certification in a $1.23 billion lawsuit accusing the pharmacy chain of systematically overcharging people who bought generic drugs using insurance rather than cash.